IEEE Trans Med Imaging. 2020 Feb;39(2):283-293. doi: 10.1109/TMI.2019.2898672. Epub 2019 Feb 12.
This paper introduces a novel, model-based chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI), in which asymmetric spectra of interest are directly estimated from complete or incomplete measurements by incorporating subspace-based spectral signal decomposition into the measurement model of CEST MRI for a robust z-spectrum analysis. Spectral signals are decomposed into symmetric and asymmetric components. The symmetric component, which varies smoothly, is delineated by the linear superposition of a finite set of vectors in a basis trained from the simulated (Lorentzian) signal vectors augmented with data-driven signal vectors, while the asymmetric component is to be inherently lower than or equal to zero due to saturation transfer phenomena. Spectral decomposition is performed directly on the measured spectral data by solving a constrained optimization problem that employs the linearized spectral decomposition model for the symmetric component and the weighted Frobenius norm regularization for the asymmetric component while utilizing additional spatial sparsity and low-rank priors. The simulations and in vivo experiments were performed to demonstrate the feasibility of the proposed method as a reliable molecular MRI.
本文提出了一种新颖的基于模型的化学交换饱和转移(CEST)磁共振成像(MRI)方法,该方法通过将基于子空间的谱信号分解纳入 CEST MRI 的测量模型中,直接从完整或不完整的测量中估计感兴趣的不对称谱,从而实现稳健的 z 谱分析。谱信号被分解为对称和不对称分量。对称分量是通过从模拟(洛伦兹)信号向量中增加数据驱动的信号向量而训练的基中的有限集合的向量的线性叠加来描绘的,该分量平滑变化,而不对称分量由于饱和转移现象而固有地低于或等于零。通过求解约束优化问题,直接在测量的谱数据上执行谱分解,该问题使用线性化的对称分量谱分解模型和不对称分量的加权 Frobenius 范数正则化,同时利用附加的空间稀疏性和低秩先验。进行了模拟和体内实验,以证明所提出的方法作为可靠的分子 MRI 的可行性。